eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Novartis Consumer Health

Novartis Consumer Health UK Ltd, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, UK
Telephone: +44 (0)1276 687300
Fax: +44 (0)1276 687284
Medical Information Direct Line: +44 (0)1403 323 046
Medical Information e-mail: medicalaffairs.uk@novartis.com
Customer Care direct line: +44 (0)1276 687290
Medical Information Fax: +44 (0)1403 324 024

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 11/02/2010
SPC Lamisil Once

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Legal category
Date of revision of text on the SPC:   23-Nov-2005
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


Change in legal category from P to GSL

All sections of SPC remain the same
Updated on 28/09/2007 and displayed until 11/02/2010
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
  • Improved Electronic Presentation
Date of revision of text on the SPC:   11/2005
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 10 : revision date changed from blank to 23 November 2005
Section 5.3 typo corrected
Updated on 22/02/2006 and displayed until 28/09/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 21/02/2006 and displayed until 22/02/2006
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   terbinafine hydrochloride